Summit Street Capital Management, LLC United Therapeutics Corp Transaction History
Summit Street Capital Management, LLC
- $267 Million
- Q4 2024
A detailed history of Summit Street Capital Management, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Summit Street Capital Management, LLC holds 32,443 shares of UTHR stock, worth $9.98 Million. This represents 4.29% of its overall portfolio holdings.
Number of Shares
32,443
Previous 36,431
10.95%
Holding current value
$9.98 Million
Previous $13.1 Million
12.32%
% of portfolio
4.29%
Previous 4.66%
Shares
15 transactions
Others Institutions Holding UTHR
# of Institutions
725Shares Held
61MCall Options Held
123KPut Options Held
104K-
Wealthfront Advisers LLC18.3MShares$5.63 Billion5.38% of portfolio
-
Black Rock Inc. New York, NY5.47MShares$1.68 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$1.37 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.76MShares$849 Million14.19% of portfolio
-
Wellington Management Group LLP Boston, MA2.46MShares$758 Million0.16% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $14B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...